Microscopic view of Cryptococcus neoformans fungi with a farmer's hand in the background.

Uncommon Infections: When a Simple Scratch Turns Serious

"A farmer's story highlights the rare but real risk of cutaneous cryptococcosis in seemingly healthy individuals."


Fungal infections are more common than many people realize, and while some are superficial and easily treated, others can be more serious. Cryptococcosis is one such infection, caused by varieties of the Cryptococcus neoformans fungus. Typically, this infection is associated with individuals who have compromised immune systems, such as those with AIDS.

However, cryptococcosis can, in rare instances, occur in individuals with healthy immune systems. This is particularly true for infections caused by Cryptococcus neoformans var. gatti, whereas C. neoformans var. neoformans is more frequent in immunodepressed patients. Understanding how these infections manifest and are treated is crucial for early intervention and successful outcomes.

This article explores a case of primary cutaneous cryptococcosis—a skin infection—in an immunocompetent patient, shedding light on the risks, diagnosis, and treatment of this rare condition. We'll delve into how a seemingly minor injury can lead to a significant health issue and what steps can be taken to ensure a full recovery.

AI Search Multiple angles on this topic

The Measurable Burden

The CDC reports that fungal diseases in the United States are associated each year with approximately 7,300 deaths and 130,000 hospitalizations. A 2024 systematic review found that Cryptococcus gattii infections account for 11%–33% of invasive cryptococcosis cases globally, with central nervous system mortality rates of 10%–23%. Another review reported that the incidence of cryptococcal meningitis in Europe and North America increased approximately twofold, from 7,400 cases in 2014 to 12,000 in 2020.

Diagnosis and Treatment Challenges

Evaluation of cutaneous cryptococcosis requires attention to its epidemiology, pathophysiology, clinical presentation, diagnostic evaluation, and treatment. For central nervous system cryptococcosis, NIH guidance generally recommends deferring antiretroviral therapy for 4 to 6 weeks after antifungal treatment begins. Laboratory susceptibility methods can use CLSI epidemiological cutoff values to categorize common Cryptococcus genotypes against amphotericin B, flucytosine, and triazoles. Primary cutaneous infection can also follow direct inoculation of Cryptococcus neoformans into wounds or damaged skin, which means a skin lesion may represent more than a routine local infection.

From Environmental Fungus to Recognized Disease

The CDC describes cryptococcosis as a fungal disease caused by breathing in spores from Cryptococcus, an organism found in the environment. The infection can affect the lungs and brain and may spread to other parts of the body. A 2025 historical review identifies 1950 as the year of the first reported possible case of primary cutaneous cryptococcosis, described by Gancy WM in the Archives of Dermatology.

A Farmer's Unexpected Fungal Infection

Microscopic view of Cryptococcus neoformans fungi with a farmer's hand in the background.

A 67-year-old farmer from Blumenau, Brazil, experienced an unusual health issue following a minor injury. While cleaning his chicken coop, he was scratched by a hen on his right arm. Shortly after, he noticed erythematous spots—red, inflamed areas—around the scratch. These spots soon developed into itchy "small blisters" that spread across his forearm, eventually turning into open wounds.

Upon dermatological examination, the farmer was found to have nodular lesions with high borders and ulcerated, depressed centers. These lesions were surrounded by multiple excoriations (scratches) and ulcerations on the anterior surface of his right forearm, accompanied by exudation and suppuration (oozing and pus).

  • General Examination: The patient was alert and oriented, hypertensive, and had normal lung sounds.
  • Laboratory Tests: Glucose levels were at 89.0/ml, total cholesterol at 232, hemoglobin at 15.5, and eosinophils at 2.0. Platelet counts were normal, and electrolyte levels (sodium and potassium) were within normal ranges. Immunoglobulin levels (IgG, IgM, and IgA) were also normal. HIV tests (HIV1 and HIV2) were non-reactive.
  • Lung X-ray: Showed no abnormalities.
  • Mycological Examination: A direct examination with India ink revealed encapsulated and gemmulated forms typical of Cryptococcus sp. Culture showed milky colonies characteristic of Cryptococcus neoformans.
AI Search Multiple angles on this topic

Recent Evidence on Primary Skin Infection

A 2024 case report states that fluconazole is the recommended medication for primary cutaneous cryptococcosis. The report emphasizes that skin infection can occur in patients at risk for opportunistic infections. Another case report describes Cryptococcus neoformans as an invasive fungus found in soil and pigeon droppings that can cause infection in susceptible immunocompromised patients. A 2022 review notes that cryptococcosis commonly involves the central nervous system and lower respiratory tract but can spread widely.

Why the Clinical Picture Remains Contested

Cryptococcosis is caused by fungi in the genus Cryptococcus, with Cryptococcus neoformans and Cryptococcus gattii recognized as important species. The disease is described as a systemic, potentially life-threatening infection caused by an encapsulated yeast-like fungus. However, controversy remains over whether primary cutaneous cryptococcosis is a distinct clinical entity, because Cryptococcus neoformans is also associated with disseminated meningitis in immunocompromised hosts.

Localized Lesions Versus Invasive Disease

Cryptococcosis is a serious invasive fungal infection caused primarily by the encapsulated yeasts Cryptococcus neoformans and Cryptococcus gattii. Cutaneous disease may occur as part of a broader systemic infection rather than as an isolated skin problem. One clinical review reports that secondary cutaneous cryptococcosis has a poor prognosis and is frequently fatal, making timely and adequate treatment critical. DermNet likewise characterizes cryptococcosis as a serious invasive infection caused primarily by these two species.

Based on these findings, the farmer was diagnosed with primary cutaneous cryptococcosis in an immunocompetent patient. The prescribed treatment was oral fluconazole at a dose of 450 mg per day for 40 days. This treatment led to complete healing, with total regression of the lesions. At a follow-up appointment 60 days later, the patient was healthy, with only residual scars.

Key Takeaways and Prevention

This case underscores that, although rare, cutaneous cryptococcosis can occur in individuals with intact immune systems. It highlights the importance of being vigilant about even minor injuries, especially when exposed to environments where fungal spores may be present, such as poultry farms.

AI Search Multiple angles on this topic

The Diagnostic Problem

A 2023 diagnostic review reports that cryptococcosis is very rare in immunocompetent patients. In that group, it can present with nonspecific clinical pictures and be challenging to diagnose. This combination of rarity and nonspecific presentation can make recognition difficult even when clinicians are evaluating a possible fungal infection.

A High-Priority Global Threat

A Lancet Medical Journal post reports that the World Health Organization classifies Cryptococcus neoformans as a Critical Priority pathogen. The post characterizes cryptococcosis as a serious global fungal infection and cites a 70% mortality rate for the pathogen. This reported classification underscores the need for continued attention to cryptococcal disease, although the source provides no further projection about future treatments or surveillance.

Skin Signs of Systemic Disease

Cutaneous cryptococcosis can range from localized skin lesions to disseminated infection involving the lungs and central nervous system. Cutaneous manifestations of disseminated cryptococcosis may appear before other signs of systemic infection. This timing makes skin findings potentially important clues to disease that has already spread beyond the skin.

Exposure and Unexpected Presentations

A 2024 case report notes that cryptococcal infection can occur through direct inoculation of fungal forms into the skin, a route commonly associated with farming activities. In another case, aspiration of cutaneous masses produced gel-like fluid containing yeast cells on microscopy, and culture identified Cryptococcus gattii. These reports show how occupational exposure and unusual skin masses can become the starting points for identifying cryptococcal infection.

While the farmer's case was successfully treated with fluconazole, early diagnosis is crucial. If you experience unusual skin lesions, especially after an injury, consult a healthcare professional promptly. Timely intervention can prevent the infection from spreading and ensure a positive outcome.

For those working in environments with potential exposure to Cryptococcus, such as farms or areas with pigeon droppings, taking preventative measures like wearing protective clothing and practicing good hygiene can reduce the risk of infection. Stay informed, stay vigilant, and prioritize your health to avoid uncommon infections.

Reported cases of primary skin infection

  • 21 casesA review identified 21 reported cases of primary cutaneous cryptococcosis in immunocompetent patients across 16 reports published from 2004 to 2014.[1]
  • 28 of 1,974 casesA French nationwide survey found 28 cases among 1,974 reported cryptococcosis cases from 1985 to 2000.[2]

What case reports can establish

These records show that primary skin infection has been documented in immunocompetent people, but reported cases do not establish how often it occurs in the wider population.[1] [2]

A favorable general prognosis in published cases does not settle which azole is preferable or whether an infection initially limited to skin can later become systemic.[1]

The rise in published reports could reflect more cases, greater physician awareness, or reporting bias; the records cannot distinguish among these explanations.[2]

How the case literature frames skin infection

The literature distinguishes primary infection, attributed to entry through the skin, from secondary disease arising after systemic infection; it also separates localized skin disease from skin involvement associated with systemic disease.[3]

Clinical suspicion is described in the setting of a single lesion on an exposed area, often an upper limb, with acute or subacute progression and no signs or symptoms of systemic disease. This is a description of a pattern, not proof that every such lesion is primary infection.[3]

A case report notes that treatment duration and follow-up were relatively short, so long-term outcomes and recurrence remain uncertain. A separate laboratory account says fluconazole susceptibility was inferred using a threshold despite clinical breakpoints for imidazole derivatives not being defined in the literature.[4] [5]

What remains unresolved about primary skin infection

  • Can researchers distinguish a genuine increase in primary cutaneous cases from increased recognition and reporting?[2]
  • Which antifungal azole is the better option, and can an infection that begins in the skin disseminate?[1]
  • How often do brief follow-up periods miss later recurrence or other long-term outcomes?[4]

Terms used in reports of skin infection

Disseminated cutaneous cryptococcosis
Skin involvement associated with systemic disease.[3]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

Is it possible to get a Cryptococcus infection even if my immune system is healthy?

Cryptococcosis, particularly when it manifests as primary cutaneous cryptococcosis, can indeed affect individuals with healthy immune systems, although it's more commonly seen in those with compromised immunity. The fungus Cryptococcus neoformans var. gatti is more often implicated in infections of immunocompetent individuals, while C. neoformans var. neoformans is more frequent in immunodepressed patients. Vigilance and awareness are important, especially if you're exposed to environments where these fungi might be present.

2

What were the specific symptoms experienced in the case of the farmer who contracted cutaneous cryptococcosis?

The farmer developed erythematous spots around the scratch, which then evolved into itchy blisters that spread and eventually turned into open wounds. Upon examination, nodular lesions with ulcerated centers were found. A mycological examination using India ink revealed encapsulated and gemmulated forms of Cryptococcus sp., and a culture confirmed Cryptococcus neoformans.

3

What exactly is primary cutaneous cryptococcosis, and how does it develop?

Primary cutaneous cryptococcosis is a skin infection caused by the Cryptococcus fungus. The infection begins when the fungus enters the skin through a wound, leading to lesions and other skin abnormalities. In the described case, a seemingly minor scratch led to a rare instance of primary cutaneous cryptococcosis.

4

What treatment options are available for cutaneous cryptococcosis, and how effective are they?

The farmer was successfully treated with oral fluconazole at a dose of 450 mg per day for 40 days. This treatment led to complete healing and regression of the lesions, with only residual scars remaining at a follow-up appointment 60 days later. Early diagnosis and appropriate antifungal treatment are essential for positive outcomes.

5

What are the broader implications of this cutaneous cryptococcosis case, and what can be done to prevent similar infections?

The farmer's diagnosis of cutaneous cryptococcosis underscores the importance of being cautious about even minor injuries, especially in environments where fungal spores may be present. This case highlights the need for heightened awareness among healthcare professionals and the general public about the possibility of rare fungal infections in immunocompetent individuals. While not specifically discussed, the environmental conditions that favor Cryptococcus growth and sporulation play a crucial role in transmission. Further research could focus on identifying these specific environmental factors to improve preventative measures.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.